Florida Senate - 2021                                    SB 1738
       
       
        
       By Senator Brodeur
       
       
       
       
       
       9-01008B-21                                           20211738__
    1                        A bill to be entitled                      
    2         An act relating to controlled substances; amending s.
    3         893.03, F.S.; excluding from Schedule I cannabis if it
    4         is contained within a pharmaceutical product approved
    5         by the United States Food and Drug Administration;
    6         providing an effective date.
    7          
    8  Be It Enacted by the Legislature of the State of Florida:
    9  
   10         Section 1. Paragraph (c) of subsection (1) of section
   11  893.03, Florida Statutes, is amended to read:
   12         893.03 Standards and schedules.—The substances enumerated
   13  in this section are controlled by this chapter. The controlled
   14  substances listed or to be listed in Schedules I, II, III, IV,
   15  and V are included by whatever official, common, usual,
   16  chemical, trade name, or class designated. The provisions of
   17  this section shall not be construed to include within any of the
   18  schedules contained in this section any excluded drugs listed
   19  within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
   20  Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
   21  Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
   22  Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
   23  Anabolic Steroid Products.”
   24         (1) SCHEDULE I.—A substance in Schedule I has a high
   25  potential for abuse and has no currently accepted medical use in
   26  treatment in the United States and in its use under medical
   27  supervision does not meet accepted safety standards. The
   28  following substances are controlled in Schedule I:
   29         (c) Unless specifically excepted or unless listed in
   30  another schedule, any material, compound, mixture, or
   31  preparation that contains any quantity of the following
   32  hallucinogenic substances or that contains any of their salts,
   33  isomers, including optical, positional, or geometric isomers,
   34  homologues, nitrogen-heterocyclic analogs, esters, ethers, and
   35  salts of isomers, homologues, nitrogen-heterocyclic analogs,
   36  esters, or ethers, if the existence of such salts, isomers, and
   37  salts of isomers is possible within the specific chemical
   38  designation or class description:
   39         1. Alpha-Ethyltryptamine.
   40         2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
   41  oxazoline).
   42         3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
   43         4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
   44         5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
   45         6. Bufotenine.
   46         7. Cannabis, except if it is contained within a
   47  pharmaceutical product approved by the United States Food and
   48  Drug Administration.
   49         8. Cathinone.
   50         9. DET (Diethyltryptamine).
   51         10. 2,5-Dimethoxyamphetamine.
   52         11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
   53         12. DMT (Dimethyltryptamine).
   54         13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
   55  analog of phencyclidine).
   56         14. JB-318 (N-Ethyl-3-piperidyl benzilate).
   57         15. N-Ethylamphetamine.
   58         16. Fenethylline.
   59         17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
   60         18. Ibogaine.
   61         19. LSD (Lysergic acid diethylamide).
   62         20. Mescaline.
   63         21. Methcathinone.
   64         22. 5-Methoxy-3,4-methylenedioxyamphetamine.
   65         23. PMA (4-Methoxyamphetamine).
   66         24. PMMA (4-Methoxymethamphetamine).
   67         25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
   68         26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
   69         27. MDA (3,4-Methylenedioxyamphetamine).
   70         28. JB-336 (N-Methyl-3-piperidyl benzilate).
   71         29. N,N-Dimethylamphetamine.
   72         30. Parahexyl.
   73         31. Peyote.
   74         32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
   75  analog of phencyclidine).
   76         33. Psilocybin.
   77         34. Psilocyn.
   78         35. Salvia divinorum, except for any drug product approved
   79  by the United States Food and Drug Administration which contains
   80  Salvia divinorum or its isomers, esters, ethers, salts, and
   81  salts of isomers, esters, and ethers, if the existence of such
   82  isomers, esters, ethers, and salts is possible within the
   83  specific chemical designation.
   84         36. Salvinorin A, except for any drug product approved by
   85  the United States Food and Drug Administration which contains
   86  Salvinorin A or its isomers, esters, ethers, salts, and salts of
   87  isomers, esters, and ethers, if the existence of such isomers,
   88  esters, ethers, and salts is possible within the specific
   89  chemical designation.
   90         37. Xylazine.
   91         38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
   92  (Thiophene analog of phencyclidine).
   93         39. 3,4,5-Trimethoxyamphetamine.
   94         40. Methylone (3,4-Methylenedioxymethcathinone).
   95         41. MDPV (3,4-Methylenedioxypyrovalerone).
   96         42. Methylmethcathinone.
   97         43. Methoxymethcathinone.
   98         44. Fluoromethcathinone.
   99         45. Methylethcathinone.
  100         46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
  101  yl)phenol) and its dimethyloctyl (C8) homologue.
  102         47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
  103  methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
  104         48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  105         49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  106         50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  107  naphthoyl)indole).
  108         51. BZP (Benzylpiperazine).
  109         52. Fluorophenylpiperazine.
  110         53. Methylphenylpiperazine.
  111         54. Chlorophenylpiperazine.
  112         55. Methoxyphenylpiperazine.
  113         56. DBZP (1,4-Dibenzylpiperazine).
  114         57. TFMPP (Trifluoromethylphenylpiperazine).
  115         58. MBDB (Methylbenzodioxolylbutanamine) or (3,4
  116  Methylenedioxy-N-methylbutanamine).
  117         59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
  118         60. 5-Hydroxy-N-methyltryptamine.
  119         61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
  120         62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
  121         63. Methyltryptamine.
  122         64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
  123         65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
  124         66. Tyramine (4-Hydroxyphenethylamine).
  125         67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
  126         68. DiPT (N,N-Diisopropyltryptamine).
  127         69. DPT (N,N-Dipropyltryptamine).
  128         70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
  129         71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
  130         72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
  131         73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
  132         74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  133         75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  134         76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  135         77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  136         78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  137         79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  138         80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  139         81. Butylone (3,4-Methylenedioxy-alpha
  140  methylaminobutyrophenone).
  141         82. Ethcathinone.
  142         83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
  143         84. Naphyrone (Naphthylpyrovalerone).
  144         85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
  145         86. 3,4-Methylenedioxy-N,N-diethylcathinone.
  146         87. 3,4-Methylenedioxy-propiophenone.
  147         88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
  148         89. 3,4-Methylenedioxy-propiophenone-2-oxime.
  149         90. 3,4-Methylenedioxy-N-acetylcathinone.
  150         91. 3,4-Methylenedioxy-N-acetylmethcathinone.
  151         92. 3,4-Methylenedioxy-N-acetylethcathinone.
  152         93. Bromomethcathinone.
  153         94. Buphedrone (alpha-Methylamino-butyrophenone).
  154         95. Eutylone (3,4-Methylenedioxy-alpha
  155  ethylaminobutyrophenone).
  156         96. Dimethylcathinone.
  157         97. Dimethylmethcathinone.
  158         98. Pentylone (3,4-Methylenedioxy-alpha
  159  methylaminovalerophenone).
  160         99. MDPPP (3,4-Methylenedioxy-alpha
  161  pyrrolidinopropiophenone).
  162         100. MDPBP (3,4-Methylenedioxy-alpha
  163  pyrrolidinobutyrophenone).
  164         101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  165         102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
  166         103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
  167  (Benocyclidine).
  168         104. F-MABP (Fluoromethylaminobutyrophenone).
  169         105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
  170         106. Et-PBP (Ethylpyrrolidinobutyrophenone).
  171         107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  172         108. Me-EABP (Methylethylaminobutyrophenone).
  173         109. Etizolam.
  174         110. PPP (Pyrrolidinopropiophenone).
  175         111. PBP (Pyrrolidinobutyrophenone).
  176         112. PVP (Pyrrolidinovalerophenone) or
  177  (Pyrrolidinopentiophenone).
  178         113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
  179         114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  180         115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  181         116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  182         117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  183         118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  184         119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  185         120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  186         121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  187  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  188         122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  189         123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  190         124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  191         125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  192         126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  193         127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  194         128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  195         129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  196         130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  197  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  198  ol).
  199         131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
  200  2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
  201  methanol).
  202         132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
  203  methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
  204  1,4-dione).
  205         133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
  206         134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
  207  undecanamide).
  208         135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
  209  undecanamide).
  210         136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
  211  methyloctan-2-yl)phenol).
  212         137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  213         138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
  214         139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  215         140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2
  216  methoxyphenylacetyl)indole).
  217         141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
  218  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  219  naphthalenylmethanone).
  220         142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
  221  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  222  naphthalenylmethanone).
  223         143. Pentedrone (alpha-Methylaminovalerophenone).
  224         144. Fluoroamphetamine.
  225         145. Fluoromethamphetamine.
  226         146. Methoxetamine.
  227         147. Methiopropamine.
  228         148. Methylbuphedrone (Methyl-alpha
  229  methylaminobutyrophenone).
  230         149. APB ((2-Aminopropyl)benzofuran).
  231         150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
  232         151. UR-144 (1-Pentyl-3-(2,2,3,3
  233  tetramethylcyclopropanoyl)indole).
  234         152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  235  tetramethylcyclopropanoyl)indole).
  236         153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  237  tetramethylcyclopropanoyl)indole).
  238         154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  239         155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  240  iodobenzoyl)indole).
  241         156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  242  carboxamide).
  243         157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)
  244  cyclohexylcarbamate).
  245         158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
  246  cyclohexyl ester).
  247         159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
  248  benzoxazin-4-one).
  249         160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  250         161. 2C-H (2,5-Dimethoxyphenethylamine).
  251         162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  252         163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  253         164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
  254  methoxybenzyl)]phenethylamine).
  255         165. MDMA (3,4-Methylenedioxymethamphetamine).
  256         166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  257         167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  258  carboxylate).
  259         168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  260  carboxylate).
  261         169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  262  3-carboxamide).
  263         170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  264  pentylindazole-3-carboxamide).
  265         171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  266  (4-fluorobenzyl)indazole-3-carboxamide).
  267         172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  268  1-pentylindazole-3-carboxamide).
  269         173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  270  yl)-1-(fluoropentyl)indole-3-carboxamide).
  271         174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
  272  methoxybenzyl)]phenethylamine).
  273         175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
  274  methoxybenzyl)]phenethylamine).
  275         176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  276  (cyclohexylmethyl)indazole-3-carboxamide).
  277         177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  278  carboxylate).
  279         178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  280  3-carboxamide).
  281         179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  282  (fluoropentyl)indazole-3-carboxamide).
  283         180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
  284         181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
  285  1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
  286         182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
  287  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  288  hexahydrobenzo[c]chromen-1-ol).
  289         183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
  290  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  291  hexahydrobenzo[c]chromen-1-ol).
  292         184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
  293  6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
  294  diol).
  295         185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
  296  dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
  297  tetrahydro-6aH-benzo[c]chromen-1-ol).
  298         186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
  299  6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
  300         187. MAPB ((2-Methylaminopropyl)benzofuran).
  301         188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
  302         189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
  303         190. Synthetic Cannabinoids.—Unless specifically excepted
  304  or unless listed in another schedule or contained within a
  305  pharmaceutical product approved by the United States Food and
  306  Drug Administration, any material, compound, mixture, or
  307  preparation that contains any quantity of a synthetic
  308  cannabinoid found to be in any of the following chemical class
  309  descriptions, or homologues, nitrogen-heterocyclic analogs,
  310  isomers (including optical, positional, or geometric), esters,
  311  ethers, salts, and salts of homologues, nitrogen-heterocyclic
  312  analogs, isomers, esters, or ethers, whenever the existence of
  313  such homologues, nitrogen-heterocyclic analogs, isomers, esters,
  314  ethers, salts, and salts of isomers, esters, or ethers is
  315  possible within the specific chemical class or designation.
  316  Since nomenclature of these synthetically produced cannabinoids
  317  is not internationally standardized and may continually evolve,
  318  these structures or the compounds of these structures shall be
  319  included under this subparagraph, regardless of their specific
  320  numerical designation of atomic positions covered, if it can be
  321  determined through a recognized method of scientific testing or
  322  analysis that the substance contains properties that fit within
  323  one or more of the following categories:
  324         a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
  325  naturally contained in a plant of the genus Cannabis, the
  326  synthetic equivalents of the substances contained in the plant
  327  or in the resinous extracts of the genus Cannabis, or synthetic
  328  substances, derivatives, and their isomers with similar chemical
  329  structure and pharmacological activity, including, but not
  330  limited to, Delta 9 tetrahydrocannabinols and their optical
  331  isomers, Delta 8 tetrahydrocannabinols and their optical
  332  isomers, Delta 6a,10a tetrahydrocannabinols and their optical
  333  isomers, or any compound containing a tetrahydrobenzo[c]chromene
  334  structure with substitution at either or both the 3-position or
  335  9-position, with or without substitution at the 1-position with
  336  hydroxyl or alkoxy groups, including, but not limited to:
  337         (I) Tetrahydrocannabinol.
  338         (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  339  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  340  ol).
  341         (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  342  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  343  ol).
  344         (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  345  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  346         (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  347  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  348         (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
  349  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  350         (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
  351  dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  352         (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
  353  6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  354         (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
  355  6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  356         (X) Parahexyl.
  357         b. Naphthoylindoles, Naphthoylindazoles,
  358  Naphthoylcarbazoles, Naphthylmethylindoles,
  359  Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
  360  compound containing a naphthoylindole, naphthoylindazole,
  361  naphthoylcarbazole, naphthylmethylindole,
  362  naphthylmethylindazole, or naphthylmethylcarbazole structure,
  363  with or without substitution on the indole, indazole, or
  364  carbazole ring to any extent, whether or not substituted on the
  365  naphthyl ring to any extent, including, but not limited to:
  366         (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  367         (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
  368  naphthoyl)indole).
  369         (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  370         (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
  371         (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  372         (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  373         (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  374         (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
  375         (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
  376         (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  377         (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  378         (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
  379         (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  380         (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
  381  naphthoyl)indole).
  382         (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
  383         (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  384         (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
  385  naphthoyl)indole).
  386         (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
  387         (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  388         (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
  389         (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
  390         (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1
  391  naphthylmethyl]indole).
  392         (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
  393  naphthoyl)indole).
  394         (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
  395  naphthoyl)indole).
  396         (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  397  naphthoyl)indole).
  398         (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  399         (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
  400         (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  401         (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
  402         (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
  403         (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
  404  naphthoyl)indole).
  405         (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
  406  naphthoyl)indole).
  407         (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
  408  naphthoyl)indole).
  409         (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1
  410  naphthoyl)indole).
  411         (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
  412  naphthoyl)indole).
  413         (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
  414         (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1
  415  naphthoyl)indazole).
  416         (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1
  417  naphthoyl)indole).
  418         (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
  419  naphthoyl)indole).
  420         (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
  421         (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1
  422  naphthoyl)carbazole).
  423         c. Naphthoylpyrroles.—Any compound containing a
  424  naphthoylpyrrole structure, with or without substitution on the
  425  pyrrole ring to any extent, whether or not substituted on the
  426  naphthyl ring to any extent, including, but not limited to:
  427         (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
  428         (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
  429         (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  430         (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  431         (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  432         (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
  433  naphthoyl)pyrrole).
  434         (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
  435  naphthoyl)pyrrole).
  436         (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
  437  naphthoyl)pyrrole).
  438         (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1
  439  naphthoyl)pyrrole).
  440         (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
  441  naphthoyl)pyrrole).
  442         d. Naphthylmethylenindenes.—Any compound containing a
  443  naphthylmethylenindene structure, with or without substitution
  444  at the 3-position of the indene ring to any extent, whether or
  445  not substituted on the naphthyl ring to any extent, including,
  446  but not limited to, JWH-176 (3-Pentyl-1
  447  (naphthylmethylene)indene).
  448         e. Phenylacetylindoles and Phenylacetylindazoles.—Any
  449  compound containing a phenylacetylindole or phenylacetylindazole
  450  structure, with or without substitution on the indole or
  451  indazole ring to any extent, whether or not substituted on the
  452  phenyl ring to any extent, including, but not limited to:
  453         (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
  454         (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  455         (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  456         (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  457         (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  458         (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  459         (VII) Cannabipiperidiethanone.
  460         (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
  461  methoxyphenylacetyl)indole).
  462         f. Cyclohexylphenols.—Any compound containing a
  463  cyclohexylphenol structure, with or without substitution at the
  464  5-position of the phenolic ring to any extent, whether or not
  465  substituted on the cyclohexyl ring to any extent, including, but
  466  not limited to:
  467         (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
  468  yl)phenol).
  469         (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
  470  homologue).
  471         (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
  472  methyloctan-2-yl)phenol).
  473         g. Benzoylindoles and Benzoylindazoles.—Any compound
  474  containing a benzoylindole or benzoylindazole structure, with or
  475  without substitution on the indole or indazole ring to any
  476  extent, whether or not substituted on the phenyl ring to any
  477  extent, including, but not limited to:
  478         (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
  479         (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  480         (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  481  iodo-5-nitrobenzoyl)indole).
  482         (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
  483  methoxybenzoyl)indole).
  484         (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  485  iodobenzoyl)indole).
  486         (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  487         (VII) RCS-4 C4 homologue (1-Butyl-3-(4
  488  methoxybenzoyl)indole).
  489         (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo
  490  3-(4-methoxybenzoyl)indole).
  491         h. Tetramethylcyclopropanoylindoles and
  492  Tetramethylcyclopropanoylindazoles.—Any compound containing a
  493  tetramethylcyclopropanoylindole or
  494  tetramethylcyclopropanoylindazole structure, with or without
  495  substitution on the indole or indazole ring to any extent,
  496  whether or not substituted on the tetramethylcyclopropyl group
  497  to any extent, including, but not limited to:
  498         (I) UR-144 (1-Pentyl-3-(2,2,3,3
  499  tetramethylcyclopropanoyl)indole).
  500         (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  501  tetramethylcyclopropanoyl)indole).
  502         (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  503  tetramethylcyclopropanoyl)indole).
  504         (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
  505  tetramethylcyclopropanoyl)indole).
  506         (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
  507  tetramethylcyclopropanoyl)indole).
  508         (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
  509  tetramethylcyclopropanoyl)indole).
  510         (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
  511  tetramethylcyclopropanoyl)indole).
  512         (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
  513  tetramethylcyclopropanoyl)indazole).
  514         (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
  515  tetramethylcyclopropanoyl)indole).
  516         (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
  517  tetramethylcyclopropanoyl)indole).
  518         i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
  519  carboxamides, and Adamantylindazole carboxamides.—Any compound
  520  containing an adamantoyl indole, adamantoyl indazole, adamantyl
  521  indole carboxamide, or adamantyl indazole carboxamide structure,
  522  with or without substitution on the indole or indazole ring to
  523  any extent, whether or not substituted on the adamantyl ring to
  524  any extent, including, but not limited to:
  525         (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  526         (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  527  3-carboxamide).
  528         (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  529  carboxamide).
  530         (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1
  531  adamantoyl)indole).
  532         (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
  533         (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
  534         (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1
  535  adamantoyl)indole).
  536         j. Quinolinylindolecarboxylates,
  537  Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
  538  and Quinolinylindazolecarboxamides.—Any compound containing a
  539  quinolinylindole carboxylate, quinolinylindazole carboxylate,
  540  isoquinolinylindole carboxylate, isoquinolinylindazole
  541  carboxylate, quinolinylindole carboxamide, quinolinylindazole
  542  carboxamide, isoquinolinylindole carboxamide, or
  543  isoquinolinylindazole carboxamide structure, with or without
  544  substitution on the indole or indazole ring to any extent,
  545  whether or not substituted on the quinoline or isoquinoline ring
  546  to any extent, including, but not limited to:
  547         (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  548         (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  549  carboxylate).
  550         (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  551  carboxylate).
  552         (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  553  carboxylate).
  554         (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
  555         (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole
  556  3-carboxylate).
  557         (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
  558  3-carboxylate).
  559         (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
  560         (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
  561  carboxamide).
  562         k. Naphthylindolecarboxylates and
  563  Naphthylindazolecarboxylates.—Any compound containing a
  564  naphthylindole carboxylate or naphthylindazole carboxylate
  565  structure, with or without substitution on the indole or
  566  indazole ring to any extent, whether or not substituted on the
  567  naphthyl ring to any extent, including, but not limited to:
  568         (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
  569  carboxylate).
  570         (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3
  571  carboxylate).
  572         (III) Fluoro SDB-005 (1-Naphthalenyl 1
  573  (fluoropentyl)indazole-3-carboxylate).
  574         (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
  575  carboxylate).
  576         (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
  577  carboxylate).
  578         l. Naphthylindole carboxamides and Naphthylindazole
  579  carboxamides.—Any compound containing a naphthylindole
  580  carboxamide or naphthylindazole carboxamide structure, with or
  581  without substitution on the indole or indazole ring to any
  582  extent, whether or not substituted on the naphthyl ring to any
  583  extent, including, but not limited to:
  584         (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
  585         (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  586  3-carboxamide).
  587         (III) Chloro-NNEI (N-Naphthalen-1-yl 1
  588  (chloropentyl)indole-3-carboxamide).
  589         (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
  590  carboxamide).
  591         (V) Fluoro MN-18 (N-Naphthalen-1-yl 1
  592  (fluoropentyl)indazole-3-carboxamide).
  593         m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
  594  indazole carboxamides, Alkylcarbonyl indole carboxylates, and
  595  Alkylcarbonyl indazole carboxylates.—Any compound containing an
  596  alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
  597  1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
  598  phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
  599  indole carboxamide, indazole carboxamide, indole carboxylate, or
  600  indazole carboxylate, with or without substitution on the indole
  601  or indazole ring to any extent, whether or not substituted on
  602  the alkylcarbonyl group to any extent, including, but not
  603  limited to:
  604         (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
  605  pentylindole-3-carboxamide).
  606         (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  607  yl)-1-(fluoropentyl)indole-3-carboxamide).
  608         (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  609  (fluoropentyl)indole-3-carboxamide).
  610         (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  611  pentylindazole-3-carboxamide).
  612         (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
  613  1-(fluoropentyl)indazole-3-carboxamide).
  614         (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  615  1-pentylindazole-3-carboxamide).
  616         (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
  617  oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
  618         (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  619  (4-fluorobenzyl)indazole-3-carboxamide).
  620         (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  621  yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  622         (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  623  (cyclohexylmethyl)indazole-3-carboxamide).
  624         (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  625  (cyclohexylmethyl)indazole-3-carboxamide).
  626         (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  627  yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  628         (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  629  pentylindazole-3-carboxamide).
  630         (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  631  (fluoropentyl)indazole-3-carboxamide).
  632         (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
  633  fluorobenzyl)indazole-3-carboxamide).
  634         (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  635  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  636         (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  637  2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  638         (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  639  2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
  640         (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  641  fluoropentyl)indole-3-carboxamide).
  642         (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  643  fluoropentyl)indazole-3-carboxamide).
  644         (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
  645  (cyclohexylmethyl)indazole-3-carboxamide).
  646         (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
  647  fluorobenzyl)indazole-3-carboxamide).
  648         (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  649  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
  650         n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
  651  Any compound containing a N-(2-phenylpropan-2-yl) indole
  652  carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
  653  structure, with or without substitution on the indole or
  654  indazole ring to any extent, whether or not substituted on the
  655  phenyl ring of the cumyl group to any extent, including, but not
  656  limited to:
  657         (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
  658  carboxamide).
  659         (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
  660  (fluoropentyl)indole-3-carboxamide).
  661         o. Other Synthetic Cannabinoids.—Any material, compound,
  662  mixture, or preparation that contains any quantity of a
  663  Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
  664         (I) With or without modification or replacement of a
  665  carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
  666  between either two core rings, or linkage between a core ring
  667  and group structure, with or without the addition of a carbon or
  668  replacement of a carbon;
  669         (II) With or without replacement of a core ring or group
  670  structure, whether or not substituted on the ring or group
  671  structures to any extent; and
  672         (III) Is a cannabinoid receptor agonist, unless
  673  specifically excepted or unless listed in another schedule or
  674  contained within a pharmaceutical product approved by the United
  675  States Food and Drug Administration.
  676         191. Substituted Cathinones.—Unless specifically excepted,
  677  listed in another schedule, or contained within a pharmaceutical
  678  product approved by the United States Food and Drug
  679  Administration, any material, compound, mixture, or preparation,
  680  including its salts, isomers, esters, or ethers, and salts of
  681  isomers, esters, or ethers, whenever the existence of such salts
  682  is possible within any of the following specific chemical
  683  designations:
  684         a. Any compound containing a 2-amino-1-phenyl-1-propanone
  685  structure;
  686         b. Any compound containing a 2-amino-1-naphthyl-1-propanone
  687  structure; or
  688         c. Any compound containing a 2-amino-1-thiophenyl-1
  689  propanone structure,
  690  
  691  whether or not the compound is further modified:
  692         (I) With or without substitution on the ring system to any
  693  extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
  694  haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
  695  dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
  696  substituents;
  697         (II) With or without substitution at the 3-propanone
  698  position with an alkyl substituent or removal of the methyl
  699  group at the 3-propanone position;
  700         (III) With or without substitution at the 2-amino nitrogen
  701  atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
  702  not further substituted in the ring system; or
  703         (IV) With or without inclusion of the 2-amino nitrogen atom
  704  in a cyclic structure, including, but not limited to:
  705         (A) Methcathinone.
  706         (B) Ethcathinone.
  707         (C) Methylone (3,4-Methylenedioxymethcathinone).
  708         (D) 2,3-Methylenedioxymethcathinone.
  709         (E) MDPV (3,4-Methylenedioxypyrovalerone).
  710         (F) Methylmethcathinone.
  711         (G) Methoxymethcathinone.
  712         (H) Fluoromethcathinone.
  713         (I) Methylethcathinone.
  714         (J) Butylone (3,4-Methylenedioxy-alpha
  715  methylaminobutyrophenone).
  716         (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
  717         (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
  718         (M) Naphyrone (Naphthylpyrovalerone).
  719         (N) Bromomethcathinone.
  720         (O) Buphedrone (alpha-Methylaminobutyrophenone).
  721         (P) Eutylone (3,4-Methylenedioxy-alpha
  722  ethylaminobutyrophenone).
  723         (Q) Dimethylcathinone.
  724         (R) Dimethylmethcathinone.
  725         (S) Pentylone (3,4-Methylenedioxy-alpha
  726  methylaminovalerophenone).
  727         (T) Pentedrone (alpha-Methylaminovalerophenone).
  728         (U) MDPPP (3,4-Methylenedioxy-alpha
  729  pyrrolidinopropiophenone).
  730         (V) MDPBP (3,4-Methylenedioxy-alpha
  731  pyrrolidinobutyrophenone).
  732         (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
  733         (X) PPP (Pyrrolidinopropiophenone).
  734         (Y) PVP (Pyrrolidinovalerophenone) or
  735  (Pyrrolidinopentiophenone).
  736         (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  737         (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
  738         (BB) F-MABP (Fluoromethylaminobutyrophenone).
  739         (CC) Me-EABP (Methylethylaminobutyrophenone).
  740         (DD) PBP (Pyrrolidinobutyrophenone).
  741         (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
  742         (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
  743         (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  744         (HH) Dimethylone (3,4-Methylenedioxy-N,N
  745  dimethylcathinone).
  746         (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
  747         (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
  748         (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
  749         (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
  750         (MM) Methylbuphedrone (Methyl-alpha
  751  methylaminobutyrophenone).
  752         (NN) Methyl-alpha-methylaminohexanophenone.
  753         (OO) N-Ethyl-N-methylcathinone.
  754         (PP) PHP (Pyrrolidinohexanophenone).
  755         (QQ) PV8 (Pyrrolidinoheptanophenone).
  756         (RR) Chloromethcathinone.
  757         (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
  758         192. Substituted Phenethylamines.—Unless specifically
  759  excepted or unless listed in another schedule, or contained
  760  within a pharmaceutical product approved by the United States
  761  Food and Drug Administration, any material, compound, mixture,
  762  or preparation, including its salts, isomers, esters, or ethers,
  763  and salts of isomers, esters, or ethers, whenever the existence
  764  of such salts is possible within any of the following specific
  765  chemical designations, any compound containing a phenethylamine
  766  structure, without a beta-keto group, and without a benzyl group
  767  attached to the amine group, whether or not the compound is
  768  further modified with or without substitution on the phenyl ring
  769  to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
  770  halide, fused alkylenedioxy, fused furan, fused benzofuran,
  771  fused dihydrofuran, or fused tetrahydropyran substituents,
  772  whether or not further substituted on a ring to any extent, with
  773  or without substitution at the alpha or beta position by any
  774  alkyl substituent, with or without substitution at the nitrogen
  775  atom, and with or without inclusion of the 2-amino nitrogen atom
  776  in a cyclic structure, including, but not limited to:
  777         a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
  778         b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  779         c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  780         d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  781         e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  782         f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  783         g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  784         h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  785         i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  786         j. 2C-H (2,5-Dimethoxyphenethylamine).
  787         k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  788         l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  789         m. MDMA (3,4-Methylenedioxymethamphetamine).
  790         n. MBDB (Methylbenzodioxolylbutanamine) or (3,4
  791  Methylenedioxy-N-methylbutanamine).
  792         o. MDA (3,4-Methylenedioxyamphetamine).
  793         p. 2,5-Dimethoxyamphetamine.
  794         q. Fluoroamphetamine.
  795         r. Fluoromethamphetamine.
  796         s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
  797         t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
  798         u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
  799         v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
  800         w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
  801         x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
  802         y. PMA (4-Methoxyamphetamine).
  803         z. N-Ethylamphetamine.
  804         aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
  805         bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
  806         cc. PMMA (4-Methoxymethamphetamine).
  807         dd. N,N-Dimethylamphetamine.
  808         ee. 3,4,5-Trimethoxyamphetamine.
  809         ff. 4-APB (4-(2-Aminopropyl)benzofuran).
  810         gg. 5-APB (5-(2-Aminopropyl)benzofuran).
  811         hh. 6-APB (6-(2-Aminopropyl)benzofuran).
  812         ii. 7-APB (7-(2-Aminopropyl)benzofuran).
  813         jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  814         kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  815         ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  816         mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  817         nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
  818         oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
  819         pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
  820         qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
  821         rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
  822         ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3
  823  dihydrobenzofuran),
  824  
  825  which does not include phenethylamine, mescaline as described in
  826  subparagraph 20., substituted cathinones as described in
  827  subparagraph 191., N-Benzyl phenethylamine compounds as
  828  described in subparagraph 193., or methamphetamine as described
  829  in subparagraph (2)(c)5.
  830         193. N-Benzyl Phenethylamine Compounds.—Unless specifically
  831  excepted or unless listed in another schedule, or contained
  832  within a pharmaceutical product approved by the United States
  833  Food and Drug Administration, any material, compound, mixture,
  834  or preparation, including its salts, isomers, esters, or ethers,
  835  and salts of isomers, esters, or ethers, whenever the existence
  836  of such salts is possible within any of the following specific
  837  chemical designations, any compound containing a phenethylamine
  838  structure without a beta-keto group, with substitution on the
  839  nitrogen atom of the amino group with a benzyl substituent, with
  840  or without substitution on the phenyl or benzyl ring to any
  841  extent with alkyl, alkoxy, thio, alkylthio, halide, fused
  842  alkylenedioxy, fused furan, fused benzofuran, or fused
  843  tetrahydropyran substituents, whether or not further substituted
  844  on a ring to any extent, with or without substitution at the
  845  alpha position by any alkyl substituent, including, but not
  846  limited to:
  847         a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
  848  methoxybenzyl)]phenethylamine).
  849         b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
  850  hydroxybenzyl)]phenethylamine).
  851         c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
  852  fluorobenzyl)]phenethylamine).
  853         d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
  854  methylenedioxybenzyl)]phenethylamine).
  855         e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
  856  methoxybenzyl)]phenethylamine).
  857         f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
  858  hydroxybenzyl)]phenethylamine).
  859         g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
  860  fluorobenzyl)]phenethylamine).
  861         h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
  862  methylenedioxybenzyl)]phenethylamine).
  863         i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
  864  methoxybenzyl)]phenethylamine).
  865         j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
  866  methoxybenzyl)]phenethylamine).
  867         k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2
  868  methoxybenzyl)]phenethylamine).
  869         l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
  870  methoxybenzyl)]phenethylamine).
  871         m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
  872  hydroxybenzyl)]phenethylamine).
  873         n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
  874  fluorobenzyl)]phenethylamine).
  875         o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
  876  methylenedioxybenzyl)]phenethylamine).
  877         p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
  878  methoxybenzyl)]phenethylamine).
  879         q. 25H-NBOH (2,5-Dimethoxy-[N-(2
  880  hydroxybenzyl)]phenethylamine).
  881         r. 25H-NBF (2,5-Dimethoxy-[N-(2
  882  fluorobenzyl)]phenethylamine).
  883         s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
  884  methoxybenzyl)]phenethylamine),
  885  
  886  which does not include substituted cathinones as described in
  887  subparagraph 191.
  888         194. Substituted Tryptamines.—Unless specifically excepted
  889  or unless listed in another schedule, or contained within a
  890  pharmaceutical product approved by the United States Food and
  891  Drug Administration, any material, compound, mixture, or
  892  preparation containing a 2-(1H-indol-3-yl)ethanamine, for
  893  example tryptamine, structure with or without mono- or di
  894  substitution of the amine nitrogen with alkyl or alkenyl groups,
  895  or by inclusion of the amino nitrogen atom in a cyclic
  896  structure, whether or not substituted at the alpha position with
  897  an alkyl group, whether or not substituted on the indole ring to
  898  any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
  899  groups, including, but not limited to:
  900         a. Alpha-Ethyltryptamine.
  901         b. Bufotenine.
  902         c. DET (Diethyltryptamine).
  903         d. DMT (Dimethyltryptamine).
  904         e. MET (N-Methyl-N-ethyltryptamine).
  905         f. DALT (N,N-Diallyltryptamine).
  906         g. EiPT (N-Ethyl-N-isopropyltryptamine).
  907         h. MiPT (N-Methyl-N-isopropyltryptamine).
  908         i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
  909         j. 5-Hydroxy-N-methyltryptamine.
  910         k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
  911         l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
  912         m. Methyltryptamine.
  913         n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
  914         o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
  915         p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
  916         q. DiPT (N,N-Diisopropyltryptamine).
  917         r. DPT (N,N-Dipropyltryptamine).
  918         s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
  919         t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
  920         u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
  921         v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
  922         w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
  923         x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
  924         y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
  925  isopropyltryptamine).
  926         z. Methyl-alpha-ethyltryptamine.
  927         aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
  928  
  929  which does not include tryptamine, psilocyn as described in
  930  subparagraph 34., or psilocybin as described in subparagraph 33.
  931         195. Substituted Phenylcyclohexylamines.—Unless
  932  specifically excepted or unless listed in another schedule, or
  933  contained within a pharmaceutical product approved by the United
  934  States Food and Drug Administration, any material, compound,
  935  mixture, or preparation containing a phenylcyclohexylamine
  936  structure, with or without any substitution on the phenyl ring,
  937  any substitution on the cyclohexyl ring, any replacement of the
  938  phenyl ring with a thiophenyl or benzothiophenyl ring, with or
  939  without substitution on the amine with alkyl, dialkyl, or alkoxy
  940  substituents, inclusion of the nitrogen in a cyclic structure,
  941  or any combination of the above, including, but not limited to:
  942         a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
  943  (Benocyclidine).
  944         b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
  945  of phencyclidine).
  946         c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
  947  analog of phencyclidine).
  948         d. PCPr (Phenylcyclohexylpropylamine).
  949         e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
  950  analog of phencyclidine).
  951         f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
  952         g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
  953         h. Methoxetamine.
  954         i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
  955         j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
  956         k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
  957         l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
  958         m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
  959         n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
  960         o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
  961         p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
  962         q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
  963         r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
  964         196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2
  965  piperidinylidene]-benzenesulfonamide.
  966         197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
  967  piperidinylidene]-benzenesulfonamide.
  968         198. AH-7921, 3,4-dichloro-N-[[1
  969  (dimethylamino)cyclohexyl]methyl]-benzamide.
  970         199. U47700, trans-3,4-dichloro-N-[2
  971  (dimethylamino)cyclohexyl]-N-methyl-benzamide.
  972         200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
  973  dihydrochloride.
  974         Section 2. This act shall take effect upon becoming a law.